Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.
Saved in:
| Title: | Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist. |
|---|---|
| Authors: | Tagat JR; Schering-Plough Research Institute, K-15-2B-2800, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, USA. jayaram.tagat@spcorp.com, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, Lachowicz J, Varty G, Watkins R |
| Source: | Journal of medicinal chemistry [J Med Chem] 2004 May 06; Vol. 47 (10), pp. 2405-8. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Print ISSN: 0022-2623 (Print) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 15115380 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tagat+JR%22">Tagat JR</searchLink>; Schering-Plough Research Institute, K-15-2B-2800, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, USA. jayaram.tagat@spcorp.com<br /><searchLink fieldCode="AU" term="%22McCombie+SW%22">McCombie SW</searchLink><br /><searchLink fieldCode="AU" term="%22Nazareno+D%22">Nazareno D</searchLink><br /><searchLink fieldCode="AU" term="%22Labroli+MA%22">Labroli MA</searchLink><br /><searchLink fieldCode="AU" term="%22Xiao+Y%22">Xiao Y</searchLink><br /><searchLink fieldCode="AU" term="%22Steensma+RW%22">Steensma RW</searchLink><br /><searchLink fieldCode="AU" term="%22Strizki+JM%22">Strizki JM</searchLink><br /><searchLink fieldCode="AU" term="%22Baroudy+BM%22">Baroudy BM</searchLink><br /><searchLink fieldCode="AU" term="%22Cox+K%22">Cox K</searchLink><br /><searchLink fieldCode="AU" term="%22Lachowicz+J%22">Lachowicz J</searchLink><br /><searchLink fieldCode="AU" term="%22Varty+G%22">Varty G</searchLink><br /><searchLink fieldCode="AU" term="%22Watkins+R%22">Watkins R</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2004 May 06; Vol. 47 (10), pp. 2405-8. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0022-2623 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15115380 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/jm0304515 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2405 Titles: – TitleFull: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tagat JR – PersonEntity: Name: NameFull: McCombie SW – PersonEntity: Name: NameFull: Nazareno D – PersonEntity: Name: NameFull: Labroli MA – PersonEntity: Name: NameFull: Xiao Y – PersonEntity: Name: NameFull: Steensma RW – PersonEntity: Name: NameFull: Strizki JM – PersonEntity: Name: NameFull: Baroudy BM – PersonEntity: Name: NameFull: Cox K – PersonEntity: Name: NameFull: Lachowicz J – PersonEntity: Name: NameFull: Varty G – PersonEntity: Name: NameFull: Watkins R IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2004 May 06 Type: published Y: 2004 Identifiers: – Type: issn-print Value: 0022-2623 Numbering: – Type: volume Value: 47 – Type: issue Value: 10 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |